An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Academy Calls for FY 2027 Investments in Hearing Health
As Congress develops the fiscal year (FY) 2027 Labor, Health and Human Services, and Education Appropriations bill, the Academy is urging targeted investments to strengthen…
CMS Moves to All Electronic Filing for Claims Documentation
The Centers for Medicare and Medicaid Services (CMS) announced on March 20, 2026, the Administrative Simplification, Adoption of Standards for Health Care Claims Attachments Transactions…
New ABN Available from CMS
As of March 13, 2026, CMS has released an updated Advanced Beneficiary Notice (ABN). The revised form carries a date of March 31, 2029, and…


